SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-167908
Filing Date
2024-06-25
Accepted
2024-06-25 16:37:55
Documents
13
Period of Report
2024-06-25
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d809055d8k.htm   iXBRL 8-K 24927
  Complete submission text file 0001193125-24-167908.txt   146856

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA grts-20240625.xsd EX-101.SCH 2854
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE grts-20240625_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grts-20240625_pre.xml EX-101.PRE 11264
16 EXTRACTED XBRL INSTANCE DOCUMENT d809055d8k_htm.xml XML 3634
Mailing Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608
Business Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608 (510) 871-6100
Gritstone bio, Inc. (Filer) CIK: 0001656634 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38663 | Film No.: 241069425
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)